Rep. Ron Wright, R-Texas, died after testing positive for COVID-19 last month, his office said on Monday, making him the first member of the U.S. Congress to die from the pandemic disease that has claimed over 464,000 American lives.
Rep. Ron Wright, R-Texas, died after testing positive for COVID-19 last month, his office said on Monday, making him the first member of the U.S. Congress to die from the pandemic disease that has claimed over 464,000 American lives.
A man has warned others to "be careful" after making an unsettling discovery behind an air vent while staying in an Airbnb.
The new "FT1000: Europe’s Fastest Growing Companies" ranking by the Financial Times and Statista was published on 2nd of March. It is a list of the European companies that achieved the highest compound annual growth rate between 2016 and 2019. For the third time in a row, Treasury Intelligence Solutions GmbH (TIS) was able to secure a spot in the ranking.
The "Europe Aerospace Coating Market Forecast to 2027 - COVID-19 Impact and Europe Analysis - By Resin Type; Technology; End-User, and Country" report has been added to ResearchAndMarkets.com's offering.
Report Scope: This report will cover the synthetic rubber industry. Definitive and detailed estimates and forecasts of the global market are provided, followed by a detailed analysis of the regions, types, applications and on-going trends.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Synthetic Rubber: Global Markets" - https://www.reportlinker.com/p06033689/?utm_source=GNW This report covers the technological, economic and business considerations of the synthetic rubber industry, with analyses and forecasts provided for global markets. Included in the report are descriptions of market forces relevant to the synthetic rubber industry and their areas of application.Global markets are presented for the size of synthetic rubber segments, along with growth forecasts through 2025.Estimates of sales value are based on the price in the supply chain.Market-driving forces and industry structure are examined.International aspects are analyzed for all global regions and types of synthetic rubber.Profiles of major global manufacturers are presented.This report considers the impact of COVID-19.In 2020, the growth rate of every industry around the world was impacted by the pandemic.The presently developing COVID-19 pandemic has currently halted the progress of every economy. In addition to taking measures to lock down their respective countries to contain the spread of the coronavirus, especially in affected cities, various governments around the world are also taking the measures necessary to contain the economic slowdown.The synthetic rubber market is further segmented based on its types: styrene butadiene rubber (SBR), Ethylene propylene diene rubber (EPDM), polybutadiene rubber (BR), polyisoprene (IR), nitrile butadiene rubber (NBR) and others. The market is also segmented into applications like tires, industrial, non-tire automotive, footwear and others.Report Includes:- 117 data tables and 39 additional tables - An overview of the global market for synthetic rubber- Estimation of the market size and analyses of market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025- Country specific data and analysis for U.S., Canada, France, Germany, Russia, Japan, China, India, and Malaysia- Market share analysis of the synthetic rubber market based on type, application, region, and on-going trends and evaluation of current market trends, market size, and market forecast- Identification of market drivers, restraints and other forces impacting the global market- Coverage of major developments in synthetic rubber market and discussion on impact of COVID-19 on synthetic rubber market- Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies- Company profiles of major players of the industry, including Exxonmobil, Goodyear Tire & Rubber Co., Zeon Corp., TSRC Corp., JSR CORP. and Kumho PetrochemicalSummary:The global synthetic rubber market totaled REDACTED million tons in 2019 and REDACTED million tons in 2020, with a growth rate of REDACTED% from 2019 to 2020. The market will reach REDACTED million tons by 2025 with a CAGR of REDACTED% from 2020 to 2025.Synthetic rubber is widely used in the automotive industry to produce tires and other rubber components in cars, busses, trucks, etc.According to International Organization of Motor Vehicle Manufacturers (OICA), in 2000, approximately REDACTED million cars were produced around the world and about REDACTED million were produced in 2015.There has been a surge in new vehicle production and consumption in developing countries like China and India, and in many Southeast Asian countries. According to National Academy of Sciences, every year, Americans spend more than $REDACTED billion replacing their passenger car and light truck tires.Companies like Bridgestone Group, Michelin, Goodyear and Continental are among those which have taken initiatives to end the use of fossil fuels in tire manufacturing and produce tires completely from sustainable materials.The Asia-Pacific makes up REDACTED% of the total synthetic rubber market, with China accounting for REDACTED% andthe rest of the Asia-Pacific totaling REDACTED%. At the end of 2016, the capacity in non-China Asia-Pacific exceeded China, as a majority of the expansions and new projects were from the rest of the Asia-Pacific region.Overcapacity is one of the biggest challenges facing the global synthetic rubber industry, with one of the major reasons being over-investment in China during the past few years. Due to overcapacity, many manufacturers are forced to work with reduced or low operating rates, and a few have also delayed expansion projects.In 2020, the automotive industry was severely hampered as manufacturing facilities were shut down and production came to standstill due to COVID-19.This resulted in a negative impact to growth rates in several countries.Some tire and synthetic rubber manufacturers decreased their production capacity or shut down a few of their facilities temporarily.Many global car manufacturers reduced their production in the first quarter of 2020 because of a lack of components from China.On the other hand, demand for synthetic rubber for glove production increased during the pandemic.Read the full report: https://www.reportlinker.com/p06033689/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Porsche has invested an additional €70 million ($83.3 million) in Rimac, boosting its stake in the hypercar manufacturer and EV component supplier from 15 to 24 percent.
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "2021 Women's Beauty Supplements Market With Covid-19 Impact: Japan" report has been added to ResearchAndMarkets.com's offering. A comprehensive analysis of the Japanese Women's Beauty Supplements Market with COVID-19 Impact, which includes market sizing, market share by competitor, drivers, restraints, regional trends and revenue forecasts to 2027. The Japanese Women's Beauty Supplements Market is mature with several dominant players present in the market. The market is projected to experience a single-digit growth rate during the forecast period (2020-2027). The prominence of the health and wellness trend, a growing elderly population wanting to age beautifully, social media, and inbound tourism are among the key factors driving the market. This study aims to provide a detailed analysis of the Japanese Women's Beauty Supplements Market along with competitive intelligence for the year 2020. The market numbers included in this report represent revenues generated from the sales of beauty supplements. The base year for the study is 2020 and the forecast period is from 2020 until 2027. For purposes of this research, beauty supplements are defined as ingestible dietary supplements offering aesthetic beauty benefits through functional foods and beverages. The report includes the following information: Market Size, Growth Rate, Revenue Forecast (2020 - 2027)Revenue Share by Application (skin care, hair care, combined care)Revenue Share by Form Factor (tablets, drinks, powders, capsules, soft gels, gummies)Revenue Share by Distribution (retail, direct sales, e-commerce, others)Revenue Share by Price RangeGrowth Drivers & RestraintsCompetitive FactorsIndustry ChallengesMarket TrendsRegional TrendsPricing TrendsRegulatory InformationMajor Company Profiles Key Topics Covered: I. Research Scope II. Methodology III. Definitions and Segmentation IV. Japanese Women's Beauty Supplements Market: Executive Summarya. Market growth trendsb. Impact of COVID-19c. Future trendsd. Competitive factorsV. Japanese Women's Beauty Supplements Market: Driversa. Anti aging supplements showing momentumb. Increasing female workforce participationc. Influence of health and wellnessd. Renewed interest from foreign players VI. Japanese Women's Beauty Supplements Market: Restraintsa. Availability of low-cost substitutesb. Supply chain disruptionc. Lack of instant results VII. Market Trendsa. Target marketb. Social mediac. Top 10 concerns for women by marketd. Collagene. Hyaluronic Acidf. Emergence of jellyg. Traditional Superfoodsh. Personalized supplementsi. Environmental sustainability and raw material transparency in souringj. Transparency in labeling and packagingk. Increasing use of clean labelsl. Functional beverages for beautym. Beauty with immunityn. Positioning by age groupo. Collaborationsp. Regulationsq. Marketing communicationr. Influencer marketings. Distribution channelt. Marketing campaigns VIII. Japan Market Dataa. Revenue forecasts, 2020 - 2027b. Market share by revenue, 2020c. Revenue share by application (skincare, hair care, combined care), 2020d. Revenue share by form factor (tablets, drinks, powders, capsules, soft gels, gummies), 2020e. Revenue share by distribution channel (retail, direct sales, e-commerce, others), 2020f. Revenue share by price, 2020 XI. Company Profiles Companies Mentioned AsahiDaigaku Honyaku Center (DHC Corporation)FANCL CorporationLimitedMeijiNissinNizonaPola Orbis Holding Inc.Shiseido CompanySuntory For more information about this report visit https://www.researchandmarkets.com/r/ls8y60 About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
CLERHP Estructuras, an Engineering and Construction company based in Murcia (Spain) and listed on the BME GROWTH, has signed a 10 million euros equity commitment with the global alternative investment firm LDA Capital.
The "Task Management Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
Thailand will from next month reduce its mandatory quarantine from 14 to seven days for foreigners arriving in the country who have been vaccinated against the coronavirus, its Health Minister said on Monday. Vaccinations must be administered within three months of the travel period and visitors will still be required to show negative COVID-19 test results within three days of their departure, Anutin Charnvirankul told a news conference. "Foreigners travelling to Thailand with vaccination certificates in accordance with the requirements of each brands, will need to quarantine for only seven days," Anutin said, referring to the doses needed to be effective.
Report Scope: The scope of this report includes an overview of the global market for nanomaterials in personalized medicine and analyses of global market trends, using 2019 as the base year and forecasting 2020 through 2025 with compound annual growth rate (CAGR) projections.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nanomaterials in Personalized Medicine: Global Markets" - https://www.reportlinker.com/p06033691/?utm_source=GNW The report is intended for professionals in the medical, medical devices, pharmaceutical, nanotechnology, materials, chemical, biological, biotechnological, and diagnostics fields.It will enable readers to understand the paradigms of personalized medicine’s new business model.A discussion of the debate between the marketing of a drug with or without its companion diagnostic kit is included. Therefore, this report is valuable for both the pharmaceutical and the medical devices industries.Additional professionals who may benefit from reading this report include analysts, sales and marketing representatives, R&D personnel, business development personnel, and corporate strategy developers. Investment firms will gain invaluable information concerning risks and opportunities encountered in the field.Market figures are based on revenues at the manufacturer level and are projected in 2019 dollar values.Inflation is not computed into the projection figures.Trends are assessed based on projected sales for existing products, for new product introductions, expanded markets for existing products, and other factors affecting the market.Included in this report are forecasts by product, product category and by company. The study is arranged to offer an overview of existing nanomaterials in personalized medicine; it is accompanied by nanoproduct, company, and mechanism of action, with forecasts broken down.Figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies. All market share data presented is on a global basis unless specifically noted.The report provides valuable insights and guidance for strategic marketing planning, understanding market drivers and limiters, and discerning sales growth opportunities.Report Includes:- 43 tables- A brief outlook of the global market for nanomaterials used in personalized medicine and pharmaceuticals within the industry- Analyses of the global market trends, with data from 2019-2020, and projections of compound annual growth rates (CAGRs) through 2025- In-depth competitive market analysis of the key industry participants, their company share analysis, global rankings and product offerings- Estimation of the actual market size and revenue forecasts for nanomaterials used in personalized medicine, and corresponding market share analysis by product type and region for each key market segment- Discussion of market potential for nanomaterial applications in medicine and pharmaceuticals, industry value chain analysis, technology updates, and market growth drivers within the segment- Insight into nanomaterial-based treatment methods for infections associated with medical devices and regulatory frameworks for personalized medicine- Evaluation of global nanotechnology patents and significant allotment of patent data- Company profiles of the leading industry players, including Novartis AG, Bristol-Myers Squibb Co., Beckman coulter, Merck & Co., Inc and Cytimmune SciencesSummary:Theranostics, the fusion of the words therapy and diagnostics, is the foundation of personalized medicine, which is a model for highly customized healthcare. Nanotechnology, which is the discipline that studies objects at the nanoscale (10-9m) level, provides an invaluable toolbox of knowledge for the study and preparation of materials for theranostics applications.Nanomaterials include biological molecules such as proteins and antibodies, and organic and inorganic synthetic materials such as liposomes, quantum dots, gold nanoparticles, nanocrystals, and fullerenes.It is expected that protein drugs and antibodies will dominate the market of theranostics through 2025.Nanomedicines are now characterized as nanoscale instruments (e.g., 1-1000 nm size) for disease diagnosis, prevention and treatment, with the potential to enable early disease detection and prevention, direct a bioactive molecule to its desired location of action, and/or monitor its release to ensure optimum concentration over a desired time frame at the therapeutic target. Nanomedicines maybe used in this sense in the field of ’precision medicine,’ consisting of a very sensitive diagnosis and focused treatment of diseases. Nanomedicines are also reported as nanodrugs, nanocarriers, Nano constructs, nanoparticles, nanomaterials, or nanotherapeutics.Personalized medicine can be defined as a healthcare strategy aimed at developing personalized therapies for each patient/group of patients, considering genetic, phenotypic and environmental factors that could affect the therapy’s outcome (efficacy and safety). There has also been an exponential increase in the use of nanomedicines in this area, as it is an opportunity to treat each person or group of individuals with common characteristics (cohorts) by considering the requirements identified in their genome.Read the full report: https://www.reportlinker.com/p06033691/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The "Middle East and Africa Aircraft Floor Panel Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Aircraft Type, Material Type, Sales Channel, and End User" report has been added to ResearchAndMarkets.com's offering.
A woman who has been charged with allegedly raping a 14-year-old boy repeatedly over the course of a year is now pregnant with his child.
(Bloomberg) -- Brent oil erased gains as the market shrugged off an attack on the world’s largest crude terminal in Saudi Arabia.Futures in London earlier surged above $71 a barrel, the highest since January 2020, before retreating to trade little changed. The assault on a storage tank farm at Ras Tanura on Sunday was intercepted, Saudi Arabia said, and oil output appeared to be unaffected.Oil has rebounded this year amid OPEC+ supply cuts and recovering demand, with economies emerging from the coronavirus crisis. The rally quickened last week after the producer alliance made a surprise pledge to keep output steady in April, prompting a raft of investment banks to raise their price forecasts.“Even though today’s risk premium will soon fade again, the economic recovery, vaccination progress, and petro-nation supply curbs point at even higher prices in the near term,” said Norbert Ruecker, an economist at Julius Baer.There was a mixed picture for crude in broader markets. U.S. President Joe Biden is on the cusp of his first legislative win, with the House ready to pass his $1.9 trillion Covid-19 relief plan. But the dollar also climbed, reducing the appeal of commodities priced in the currency, while U.S. equity futures deepened losses.Monday’s earlier Brent rally north of $70 may cause a headache for Asian refiners, which are warning that the rapid surge and spike in volatility will hurt demand and whittle away still-tight processing margins. Saudi Arabia has also boosted its official selling prices to buyers in the region for April.Mideast TensionsSaudi Arabia said the Ras Tanura site on the country’s Gulf coast was targeted by a drone from the sea. The terminal is capable of exporting about 6.5 million barrels a day -- almost 7% of demand -- and, as such, is one of the world’s most protected facilities. It’s the most serious attack on Saudi oil installations since a key processing facility and two oil fields came under fire in September 2019.See also: Three Reasons Attack Won’t Spike Oil Prices: David FicklingThe assault follows a recent escalation of hostilities in the Middle East region after Yemen’s Houthi rebels launched a series of attacks on Saudi Arabia. The new U.S. administration also carried out airstrikes in Syria last month on sites it said were connected with Iran-backed groups.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "NGOs and Charitable Organizations Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global NGOs and charitable organizations market as it emerges from the COVID-19 shut down. The global NGOs and charitable organizations market is expected to grow from $279.81 billion in 2020 to $285.5 billion in 2021 at a compound annual growth rate (CAGR) of 2%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $369.6 billion in 2025 at a CAGR of 7%.Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.Create regional and country strategies on the basis of local data and analysis.Identify growth segments for investment.Outperform competitors using forecast data and the drivers and trends shaping the market.Understand customers based on the latest market research findings.Benchmark performance against key competitors.Utilize the relationships between key data sets for superior strategizing.Suitable for supporting your internal and external presentations with reliable high quality data and analysis Description: Where is the largest and fastest growing market for the ngos and charitable organizations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The NGOs and Charitable Organizations market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider ngos and charitable organizations market, and compares it with other markets. The market characteristics section of the report defines and explains the market.The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.Market segmentations break down market into sub markets.The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.The ngos and charitable organizations market section of the report gives context. It compares the ngos and charitable organizations market with other segments of the civic services market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, ngos and charitable organizations indicators comparison. Major companies in the NGOs and charitable organizations market include Wikimedia; BRAC; Acumen Fund; Cure Violence and Medecins Sans Frontiers.The NGOs and charitable organizations market consists of sales of NGO and charitable services by entities (organizations, sole traders and partnerships) that are involved in grantmaking foundations or charitable trusts and establishments primarily engaged in raising funds for a wide range of social welfare activities, such as health, educational, scientific, and cultural activities. The NGOs and charitable organizations market is segmented into trust and foundations; voluntary health organizations; human rights organizations; environment, conservation and wildlife organizations; and other NGOs And charitable organizations.Asia Pacific was the largest region in the global ngos and charitable organizations market, accounting for 38% of the market in 2020. North America was the second largest region accounting for 29% of the global ngos and charitable organizations market. Africa was the smallest region in the global ngos and charitable organizations market.NGOs and charitable organizations are increasingly investing in customer relationship management (CRM) software to track donations and manage donor contact information. CRM software offers multiple functionalities such as email, phone, activity tracking, customer communication and others in a single system without having to use multiple software tools. CRM software also provides efficient data management and secure storage of donor contact information using cloud and encryption technology. According to the Global NGO Technology Report, 45% of the surveyed NGOs use CRM software to track donations and manage donor communications. For instance, the Bill & Melinda Gates Foundation, a charitable foundation uses SpringCM for document management and Salesforce for customer relationship management.Key Topics Covered: 1. Executive Summary 2. Report Structure 3. NGOs and Charitable Organizations Market Characteristics 3.1. Market Definition 3.2. Key Segmentations 4. NGOs and Charitable Organizations Market Product Analysis 4.1. Leading Products/ Services 4.2. Key Features and Differentiators 4.3. Development Products 5. NGOs and Charitable Organizations Market Supply Chain 5.1. Supply Chain 5.2. Distribution 5.3. End Customers 6. NGOs and Charitable Organizations Market Customer Information 6.1. Customer Preferences 6.2. End Use Market Size and Growth 7. NGOs and Charitable Organizations Market Trends and Strategies 8. Impact of COVID-19 on NGOs and Charitable Organizations 9. NGOs and Charitable Organizations Market Size and Growth 9.1. Market Size 9.2. Historic Market Growth, Value ($ Billion) 9.2.1. Drivers of the Market 9.2.2. Restraints on the Market 9.3. Forecast Market Growth, Value ($ Billion) 9.3.1. Drivers of the Market 9.3.2. Restraints on the Market 10. NGOs and Charitable Organizations Market Regional Analysis 10.1. Global NGOs and Charitable Organizations Market, 2020, by Region, Value ($ Billion) 10.2. Global NGOs and Charitable Organizations Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region 10.3. Global NGOs and Charitable Organizations Market, Growth and Market Share Comparison, by Region 11. NGOs and Charitable Organizations Market Segmentation11.1. Global NGOs and Charitable Organizations Market, Segmentation by Type11.2. Global NGOs and Charitable Organizations Market, Segmentation by Mode of Donation11.3. Global NGOs and Charitable Organizations Market, Segmentation by Organisation Location 12. NGOs and Charitable Organizations Market Metrics 12.1. NGOs and Charitable Organizations Market Size, Percentage of GDP, 2015-2025, Global 12.2. Per Capita Average NGOs and Charitable Organizations Market Expenditure, 2015-2025, Global 13. Asia-Pacific NGOs and Charitable Organizations Market 14. Western Europe NGOs and Charitable Organizations Market 15. Eastern Europe NGOs and Charitable Organizations Market 16. North America NGOs and Charitable Organizations Market 17. South America NGOs and Charitable Organizations Market 18. Middle East NGOs and Charitable Organizations Market 19. Africa NGOs and Charitable Organizations Market 20. NGOs and Charitable Organizations Market Competitive Landscape 20.1. Competitive Market Overview 20.2. Market Shares 20.3. Company Profiles 20.3.1. Wikimedia 188.8.131.52. Company Overview 184.108.40.206. Products and Services 220.127.116.11. Strategy 18.104.22.168. Financial Performance 20.3.2. BRAC 22.214.171.124. Company Overview 126.96.36.199. Products and Services 188.8.131.52. Strategy 184.108.40.206. Financial Performance 20.3.3. Acumen Fund 220.127.116.11. Company Overview 18.104.22.168. Products and Services 22.214.171.124. Strategy 126.96.36.199. Financial Performance 20.3.4. Cure Violence 188.8.131.52. Company Overview 184.108.40.206. Products and Services 220.127.116.11. Strategy 18.104.22.168. Financial Performance 20.3.5. Medecins Sans Frontiers 22.214.171.124. Company Overview 126.96.36.199. Products and Services 188.8.131.52. Strategy 184.108.40.206. Financial Performance 21. Key Mergers and Acquisitions in the NGOs and Charitable Organizations Market 22. Market Background: Civic Services Market 22.1. Civic Services Market Characteristics 22.2. Civic Services Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global 22.3. Global Civic Services Market, 2020, by Region, Value ($ Billion) 22.4. Global Civic Services Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region 22.5. Global Civic Services Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion) 23. Recommendations 23.1. Global NGOs and Charitable Organizations Market in 2025 - Growth Countries 23.2. Global NGOs and Charitable Organizations Market in 2025 - Growth Segments 23.3. Global NGOs and Charitable Organizations Market in 2025 - Growth Strategies 24. Appendix 24.1. NAICS Definitions of Industry Covered in this Report 24.2. Abbreviations 24.3. Currencies 24.4. Research Inquiries 24.5. About the Publisher25. Copyright and Disclaimer For more information about this report visit https://www.researchandmarkets.com/r/dpb1ao CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The Fed has said 'yield curve control' is a tool it could use to address rising bond yields. But how would that work?
German technology group Bosch said on Monday it would open an automotive chip factory in Dresden in June to build on its leadership in sensor chips that will boost the electric car industry. The 1 billion euro ($1.2 billion) plant will produce sensor chips to be installed in electric and hybrid electric vehicles. The chips help increase the range of electric vehicles.
8 March 2021 LSE Code: VIXL WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE S&P 500 VIX SHORT-TERM FUTURES 2.25X DAILY LEVERAGED SECURITIES (ISIN: IE00BLRPRH06) PROPOSALS FOR THE CHANGE OF INDEX OF THE AFFECTED SECURITIES WITH A CONNECTED REDUCTION IN DAILY SWAP RATE NOTICE OF CORRECTION AND CHANGE OF DATE IN RESPECT OF THE MEETING OF THE ETP SECURITYHOLDERS CONVENED BY THE CIRCULAR DATED 12 FEBRUARY 2021 THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities (the “Affected Securities”) of Wisdomtree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser or transferee or stockbroker, banker or other agent through whom the sale or transfer was made, for onward transmission to the purchaser or transferee. The Issuer refers to a circular dated 12 February 2021 (the “Original Circular”). The Original Circular purported to convene a meeting of the holders of the Affected Securities at 11 a.m. on Wednesday, 10 March 2021 (the “Original Meeting”). The Issuer has been made aware that due to technical and operational reasons the Original Circular was not fully and properly notified to ETP Securityholders in accordance with the conditions of the Affected Securities. As such the Original Meeting was not validly convened and will not be held. The Issuer hereby announces a correction to the Original Circular. A corrected notice of meeting along with an updated form of proxy is enclosed to this Notice of Correction. The meeting of the Affected Securities will now be convened at 11.00 a.m. on 7 April 2021 in the same manner and place as set out in the Original Circular (the “Meeting”). ETP Securityholders are encouraged to ignore the details of the Original Meeting. ETP Securityholders should make arrangements to vote at the Meeting as detailed herein. For proxies to be accepted, the Issuer must receive the relevant proxies by not later than 11.00 a.m. on 5 April 2021 (or, in the event that the Meeting is adjourned, not later than 11.00 a.m. on the day that falls two days before the time of Adjourned Meeting). As the Affected Securities of the Issuer use the International Central Securities Depositary (ICSD) model of settlement and Citivic Nominees Limited is the sole registered Holder of Affected Securities under the ICSD settlement model, Holders of the Affected Securities should submit their voting instructions through the relevant ICSD or the relevant participant in an ICSD (such as a local central securities depositary, broker or nominee). Holders of Affected Securities should also note that the deadlines set by any intermediary or by Euroclear or Clearstream, Luxembourg (together the “ICSDs”) will be earlier than the deadlines set out in this notice of correction. Holders of the Affected Securities are advised to check with any bank, securities broker or other intermediary through which they hold their Affected Securities when such intermediary would need to receive instructions from a holder of the Affected Securities in order for such holder of the Affected Securities to participate in the Meeting by the deadlines specified in this circular. The deadlines set by any such intermediary and each ICSD for the submission instructions will be earlier than the relevant deadlines specified in this circular. Holders of the Affected Securities are responsible for complying with all of the procedures for participating in the Meeting. None of the Issuer, the Manager or the Trustee, or any of their respective directors, officers, employees, agents, representatives or affiliates, assumes any responsibility for informing holders of the Affected Securities of irregularities with respect to compliance with such procedures. In relation to the delivery instructions or obtaining voting certificates or otherwise making arrangements for the giving of voting instructions, in each case through the ICSDs, holders of the Affected Securities should note the particular practice and policy of the relevant ICSDs, including any earlier deadlines set by such ICSD. This may include the requirement to resubmit votes in relation to any adjourned meeting. The Meeting is being held to consider proposals for the change of Index of the Affected Securities with a connected reduction in Daily Swap Rate. Full details of the Proposal and Extraordinary Resolution are set out in the Original Circular. Holders of the Affected Securities are therefore directed to the original notification made public on 12 February 2021, and also available on the website of the Issuer, at https://www.wisdomtree.eu/en-gb/-/media/eu-media-files/other-documents/operational/corp-action/boost/rns-corporate-actions/vixl-index-switch-circular_2021.pdf. Holders of the Affected Securities have received a form of proxy by post in respect of the Original Meeting (the “Original Proxy”). Holders of the Affected Securities should note that a duly completed Original Proxy deposited in respect of the Original Meeting will continue to be valid for the Meeting unless previously revoked or suspended by a further form of proxy prior to the Meeting. In accordance with normal practice, The Law Debenture Trust Corporation p.l.c., as trustee, expresses no opinion as to the merits of the proposals, the terms of which were not negotiated by it. It has however authorised it to be stated that, on the basis of the information contained in the Original Circular and in this document (which it advises holders of Affected Securities to read carefully) it has no objection to the form in which the proposals and Notice of Meeting are presented to holders of Affected Securities for their consideration. Holders of the Affected Securities will be notified of the outcome of the Meeting shortly thereafter. NOTICE OF MEETING WISDOMTREE MULTI ASSET PUBLIC LIMITED COMPANY Notice of a meeting of the holders (the “Affected Securities Holders”) of the WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities (the “Affected Securities”) of the Issuer NOTICE is hereby given that, pursuant to the provisions of the Trust Deed dated 30 November 2012, as supplemented and amended constituting (inter alia) the Affected Securities and made between (1) WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), (2) The Law Debenture Trust Corporation p.l.c. (the “Trustee”) and (3) WisdomTree Multi Asset Management Limited (the “Manager”), as amended, a meeting of the Affected Security Holders convened by the Issuer will be held by way of virtual meeting (due to ongoing social distancing measures in relation to the COVID-19 pandemic it is impractical and inadvisable to hold a physical meeting) on Wednesday, 7 April 2021 at 11.00am local time for the purpose of considering and, if thought fit, passing the following resolution which will be proposed as an Extraordinary Resolution of the Affected Securities Holders pursuant to the terms of the Trust Deed. EXTRAORDINARY RESOLUTION “THAT this meeting of the holders (the “Affected Securities Holders”) of the WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”) constituted by the Master Trust Deed dated 30 November 2012 (as subsequently amended) and as supplemented by a Supplemental Trust Deed dated 16 March 2016 (as amended) (the “Trust Deed”) and made between the Issuer, WisdomTree Multi Asset Management Limited (the “Manager”) and The Law Debenture Trust Corporation p.l.c. as Trustee (the “Trustee”) for (inter alios) the Affected Securities Holders, hereby: pursuant to Paragraph 2, Schedule 7 of the Master Trust Deed, sanctions and consents to the following amendments: change of the Index of the Affected Securities from “S&P 500 VIX Short-term Futures Index ER” to “S&P 500 VIX Short-term Futures Index (0930-1600 ET) (USD) ER”;Decrease the Daily Swap Rate from “0.01181 per cent. per day” to 0.00966 per cent. per day; together, the “Proposals”; assents to the modification of the Trust Deed on the terms set out in the draft of a deed of amendment (substantially in the form of the draft produced to the meeting and signed for the purposes of identification by the Chairman) (the “Deed of Amendment”) in order to give effect to and to implement the Proposals and this Extraordinary Resolution at any time after the passing of this Extraordinary Resolution, together with any minor consequential modifications (if any) thereto agreed between the parties;consents to, sanctions, requests, empowers, ratifies, approves, authorises, directs and instructs the Trustee to concur in and execute the Deed of Amendment with the Issuer embodying the Proposals referred to in paragraph (1) of this Extraordinary Resolution in substantially the form of the draft produced to the meeting and signed for the purposes of identification by the Chairman (with such additions or modifications, if any, as shall be agreed between the Issuer, the Manager and the Trustee);generally sanctions, authorises, directs, instructs and empowers the Trustee, the Manager and the Issuer to concur in and execute and do, all such other deeds, instruments, acts and things as may be necessary or desirable to carry out and give effect to this Extraordinary Resolution and the implementation of the Proposals;holds harmless, discharges and exonerates the Trustee from and against any and all liability which it has or may have become responsible for under the Trust Deed, the Affected Securities or any other transaction documents or otherwise in respect of any act or omission, including, without limitation, in connection with this Extraordinary Resolution or its implementation, such modifications or the implementation of those modifications (including, for the avoidance of doubt, the directions and/or information contained herein) and irrevocably waives any claims against the Trustee for complying with the directions given in paragraphs (3) and (4) of this Extraordinary Resolution even though it may subsequently be found that there is a defect in the passing of this Extraordinary Resolution or that for any reason this Extraordinary Resolution is not valid or binding on the Affected Securities Holders;authorises, approves, acknowledges and instructs the Trustee not to obtain any legal opinions in relation to, or to make any investigation or enquiry into, the power and capacity of any person to enter into the Deed of Amendment, or the validity or enforceability thereof and confirms that the Trustee shall not be liable to the Affected Securities Holders for the failure to do so or for any consequences resulting from following the directions given by the Affected Securities Holders in this Extraordinary Resolution;assents to, approves and sanctions every abrogation, modification, waiver, compromise or arrangement in respect of the rights of the Affected Securities Holders against the Issuer (whether or not such rights arise under the Trust Deed, the Affected Securities or otherwise) if, and to the extent, that they result from the modifications and amendments referred to in paragraphs (1) and (2) above;irrevocably waives any claim that Affected Securities Holders may have against the Trustee arising as a result of any loss or damage which Affected Securities Holders may suffer or incur as a result of the Trustee acting on this Extraordinary Resolution and/or entry into and effectiveness of the Deed of Amendment and performance under the Trust Deed (including but not limited to circumstances where it is subsequently found that this resolution is not valid or binding on the ETP Securityholders) and further confirms that Affected Securities Holders will not seek to hold the Trustee liable for such loss or damage;agrees that this Extraordinary Resolution shall take effect as an extraordinary resolution pursuant to paragraph 2 (Powers of a Meeting) of Schedule 7 (Provisions for Meetings of ETP Securityholders) of the Trust Deed;acknowledges that the Proposals contemplated by this Extraordinary Resolution will not become effective until the Deed of Amendment is executed by all the parties thereto; andconfirms that terms used in this Extraordinary Resolution and not otherwise defined bear the same meanings as in the Trust Deed.” WisdomTree Multi Asset Issuer Public Limited CompanyBy Order of the Board Apex IFS Limited2nd Floor. Block 5Irish Life Centre, Abbey Street Lower Dublin 1, D01P767IrelandSecretary Monday, 8 March 2021 NOTES 1. As the Affected Securities of the Issuer use the International Central Securities Depositary (ICSD) model of settlement and Citivic Nominees Limited is the sole registered Holder of Affected Securities under the ICSD settlement model, Holders of the Affected Securities should submit their voting instructions through the relevant ICSD or the relevant participant in an ICSD (such as a local central securities depositary, broker or nominee). 2. The quorum for passing an Extraordinary Resolution shall be two or more persons being Affected Securities Holders present in person or by proxy or (in the case of an Affected Securities Holder which is a corporation) by its duly authorised representative and holding or representing in the aggregate in the aggregate more than 50 per cent. of the number of Affected Securities for the time being outstanding.3. On a show of hands every Affected Securities Holder who is present in person or by proxy or (in the case of an Affected Securities Holder which is a corporation) by its duly authorised representative shall have one vote. On a poll every Affected Securities Holder who is so present shall have one vote in respect of each Affected Securities of which it is the holder or in respect of which it is the proxy or duly authorised representative. Extraordinary Resolutions are passed by a majority of at least 75 per cent of the votes cast at a duly convened meeting.4. If within 15 minutes (or such longer period not exceeding 30 minutes as the Chairman may decide) from the time appointed for holding the Meeting a quorum is not present, the Meeting will stand adjourned to such day and time being not less than 14 nor more than 42 calendar days later and to such place as may be appointed by the Chairman and at such adjourned meeting the quorum will be two or more persons being Affected Securities Holders present in person or by proxy or (in the case of an Affected Securities Holder which is a corporation) by its duly authorised representative whatever the aggregate face value of the Affected Securities for the time being outstanding held or represented by them.5. Only those Affected Securities Holders registered in the register of Affected Securities Holders as at 6.00 p.m. on 5 April 2021 (or, in the event that the Meeting is adjourned, on the register of Affected Securities Holders at 6.00 p.m. on the day that falls two days before the time of any adjourned meeting) shall be entitled to attend or vote at the Meeting in respect of the Affected Securities registered in their name at that time. Changes to entries on the register of Affected Securities Holders after 6.00 p.m. on 5 April 2021 shall be disregarded in determining the rights of any person to attend or vote at the Meeting (or adjourned meeting). WisdomTree Multi Asset Issuer Public Limited Company WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities (the “Affected Securities”) Form of Proxy in respect of a meeting (the “Meeting”) of holders of Affected Securities (the “Affected Security Holders”) I/We ______________________________________________ being an Affected Security Holder of the above named Affected Securities hereby appoint the Chairman of the Meeting or (see note 1 below) Name(s): ……………………………………………………………………………………….. Address: ………………………………………………………………………………………… to attend as my/our proxy and to vote for me/us and on my behalf all Affected Securities (or such lesser number of Affected Securities as I/we hereby indicate ________________) held by me/us at the meeting to be held at 11.00 am (local time) on 7 April 2021 and at any adjournment thereof (the “Adjourned Meeting”). Signature or common seal Name ……………………………………………………………………………………….. Position ……………………………………………………………………… (e.g. Authorised Signatory) Dated …………………………… Please indicate with an "X" in the space below how you wish your vote to be cast (see note 6). Extraordinary Resolution (see note 3)For Against1. To approve the proposal as set out in the attached Notice of Meeting (1) to (11) inclusive. NOTES An Affected Security Holder entitled to attend and vote at the Meeting is also entitled to appoint one or more proxies to attend and vote instead of him or her. The proxy need not be an Affected Security Holder. If more than one proxy is appointed a separate form of proxy should be completed for each person appointed and each form of proxy should show the number of Securities to which it relates.Unless you wish to authorise your proxy to act in respect of your full voting entitlement (or if this proxy form has been issued in respect of a designated account for an Affected Security Holder, the full voting entitlement for that designated account), please specify the number of Securities in relation to which they are authorised to act. In the absence of any such specification, the proxy shall be authorised to act in respect of the full voting entitlement.The extraordinary resolution is set out in full in notice of meeting set out at the end of the accompanying notice of correction dated 8 March 2021.To be effective, the instrument appointing a proxy and the power of attorney or other authority (if any) under which it is signed or a certified copy of such power or authority must be deposited by the registered holder at the office of Link Registrars Limited, PO Box 1110, Maynooth, Co. Kildare, Ireland (if by post) or by Link Registrars Limited, Block C, Maynooth Business Campus, Maynooth, Co Kildare, W23 F854 (if delivered by hand) not later than 11.00 a.m. on 5 April 2021 (or, in the event that the Meeting is adjourned, not later than 11.00 a.m. on the day that falls two days before the time of Adjourned Meeting). Completion and return of the form of proxy will not preclude an Affected Security Holder from attending and voting in person at the Meeting. As the Affected Securities of the Issuer use the International Central Securities Depositary (ICSD) model of settlement and Citivic Nominees Limited is the sole registered Holder of Affected Securities under the ICSD settlement model, Holders of the Affected Securities should submit their voting instructions through the relevant ICSD or the relevant participant in an ICSD (such as a local central securities depositary, broker or nominee), instead of submitting this Form of Proxy to the Link Registrars Limited.The quorum for passing an Extraordinary Resolution shall be two or more persons being Affected Security Holders present in person or by proxy or (in the case of an Affected Security Holder which is a corporation) by its duly authorised representative and holding or representing in the aggregate not less than 50 per cent of the number of Affected Securities for the time being outstanding. At an Adjourned Meeting the quorum for passing an Extraordinary Resolution shall be two or more persons being Affected Security Holders present in person or by proxy or (in the case of an Affected Security Holder which is a corporation) by its duly authorised representatives, whatever the aggregate face value of the Affected Securities for the time being outstanding held or represented by them.If you sign and return this form without any indication as to how the proxy is to vote, the Chairman will exercise their discretion both as to how they vote on any resolution put to the Meeting. On a show of hands every Affected Security Holder who is present in person or by proxy or (in the case of an Affected Security Holder which is a corporation) by its duly authorised representative shall have one vote. On a poll every Affected Security Holder who is so present shall have one vote in respect of each Affected Security of which it is the holder or in respect of which it is the proxy or duly authorised representative. Extraordinary Resolutions are passed by a majority of at least 75 per cent of the votes cast at a duly convened meeting.If within 15 minutes (or such longer period not exceeding 30 minutes as the Chairman may decide) from the time appointed for holding the Meeting a quorum is not present, the Meeting will stand adjourned to such day and time being not less than 14 nor more than 42 calendar days later (or, in the case of a meeting called to consider the reduction of the Principal Amount of the ETP Securities following a Threshold Redemption Event only, not more than 30 calendar days) and to such place as may be appointed by the Chairman and at such Adjourned Meeting the quorum will be two or more persons being Affected Security Holders present in person or by proxy or (in the case of an Affected Security Holder which is a corporation) by its duly authorised representative whatever the aggregate face value of the Affected Securities for the time being outstanding held or represented by them.Only those Affected Security Holders registered in the register of Affected Security Holders as at 6:00 p.m. on 5 April 2021 (or, in the event that the Meeting is adjourned, on the register of Affected Security Holders at 6:00 p.m. on the day that falls two days before the time of any Adjourned Meeting) shall be entitled to attend or vote at the Meeting in respect of the Affected Securities registered in their name at that time. Changes to entries on the register of Affected Security Holders after 6:00 p.m. on 5 April 2021 (or, in the event that the Meeting is adjourned, on the register of Affected Security Holders after 6:00 p.m. on the day that falls two days before the time of Adjourned Meeting) shall be disregarded in determining the rights of any person to attend or vote at the Meeting (or Adjourned Meeting).Any alteration made to this form of proxy should be initialled by the person(s) signing it.In the case of joint holders, the vote of the senior (according to the order in which the names stand in the register in respect of the holding) who tenders a vote in person or by proxy will be accepted to the exclusion of the votes of the other joint holder(s).
The "Europe Antifreeze Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type, Technology Type, and Application" report has been added to ResearchAndMarkets.com's offering.
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:DOWNING STRATEGIC MICRO-CAP INVESTMENT TRUST PLC1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an “X”)An acquisition or disposal of voting rightsx An acquisition or disposal of financial instruments An event changing the breakdown of voting rights Other (please specify)iii: 3. Details of person subject to the notification obligationivNamePREMIER MITON GROUP PLCCity and country of registered office (if applicable)London, UK4. Full name of shareholder(s) (if different from 3.)vName City and country of registered office (if applicable) 5. Date on which the threshold was crossed or reachedvi:02/03/20216. Date on which issuer notified (DD/MM/YYYY):03/03/20217. Total positions of person(s) subject to the notification obligation % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights of issuerviiResulting situation on the date on which threshold was crossed or reached9.96%N/A9.96%5,220,253Position of previous notification (if applicable)10.95%N/A10.95% 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviiiA: Voting rights attached to sharesClass/type of sharesISIN code (if possible)Number of voting rightsix% of voting rightsDirect(Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1)Direct(Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1)GB00BF0SCX52 5,220,253 9.96% SUBTOTAL 8. A5,220,2539.96% B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR220.127.116.11 (a))Type of financial instrumentExpiration datexExercise/ Conversion PeriodxiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rights SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR18.104.22.168 (b))Type of financial instrumentExpiration datexExercise/ Conversion Period xiPhysical or cash settlementxiiNumber of voting rights % of voting rights SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)XNamexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable thresholdPremier Miton Group Plc Premier Asset Management Midco Ltd Premier Asset Management Holdings Ltd Premier Asset Management Limited Premier Investment Group Ltd Premier Fund Managers Ltd9.96% 9.96% 10. In case of proxy voting, please identify:Name of the proxy holderN/AThe number and % of voting rights heldN/AThe date until which the voting rights will be heldN/A 11. Additional informationxviPlease note that with effect from 27th April 2020 all investment management related activities for the Premier Miton Group plc will be carried out by Premier Fund Managers Limited. Miton Asset Management Limited and Miton Trust Managers Limited have ceased to carry out regulated activities. Place of completionLONDON, UKDate of completion03/03/2021
Summary Surgical Energy Instruments (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Surgical Energy Instruments (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact)" - https://www.reportlinker.com/p05948843/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Surgical Energy Instruments market for the year 2020 and beyond.Surgical Energy is used in numerous procedures spanning across multiple therapeutic areas and fields of expertise.In regard to General Surgery, surgical energy is utilized whenever tissue needs to be cut, coagulated or sealed with minimal blood loss.The procedures include open surgery and laparoscopic surgeries and can be used in specific procedures covered under OB-GYN, urology, oncology, cardiovascular, etc.Surgery Energy instruments includes the basic, advanced and alternative energy instruments.Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).Moreover, analyst comments with qualitative insight offer context for quantitative data.Key Inclusions of the market model are -Currently marketed Surgical Energy Instruments and evolving competitive landscape -- Insightful review of the key industry trends.- Annualized total Surgical Energy Instruments market revenue by segment and market outlooks from 2015-2030.- Granular data on total procedures, units, average selling prices and market values by segment.Global, Regional and Country level market specific insights -- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.- SWOT analysis for Surgical Energy Instruments market.- Competitive dynamics insights and trends provided for Surgical Energy Instruments market.Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.- Country specific overview of the healthcare system.- Country specific reimbursement policies.- Country specific medtech regulatory landscape.Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.Companies covered: Medtronic Plc, Johnson & Johnson, Olympus Corp, B. Braun Melsungen AG , ERBE Elektromedizin GmbH and OthersCountries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.ScopeThis Market Model gives important, expert insight you won’t find in any other source.The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -- CMO executives who must have deep understanding of the Surgical Energy Instruments marketplace to make strategic planning and investment decisions.- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.Reasons to BuyThe model will enable you to -- Understand the impact of COVID-19 on Surgical Energy Instruments market.- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving Surgical Energy Instruments market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Surgical Energy Instruments market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Track device sales in the global and country-specific Surgical Energy Instruments market from 2015-2030.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.Read the full report: https://www.reportlinker.com/p05948843/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001